Skip to main content
Top
Published in: Rheumatology International 7/2016

01-07-2016 | Cases with a Message

Systemic lupus erythematosus-related hypercalcemia with ectopic calcinosis

Authors: Lidan Zhao, Linfang Huang, Xuan Zhang

Published in: Rheumatology International | Issue 7/2016

Login to get access

Abstract

We report a case of a 39-year-old female with active systemic lupus erythematosus who complained of lethargy and weakness with a moderate renal impairment. Hypercalcemia was confirmed by laboratory examination. Her X-ray revealed significant ectopic calcinosis in subcutaneous tissue of bilateral hands, and Tc-99m methylene diphosphonate bone scan revealed a remarkably intense uptake of bilateral lungs. She had no evidence suggestive of other diseases related to hypercalcemia such as hyperparathyroidism and malignancy. She had abnormally high serum parathyroid hormone-related protein (PTHrP) which fell to normal after treatment. Glucocorticoid, cyclophosphamide plus calcitonin and etidronate were administered and the patient improved greatly. Literature review demonstrated that lupus-related hypercalcemia with ectopic calcinosis is a rare complication and increased PTHrP is probably one of the main mechanisms. Lung uptake in bone scan may be a special and reliable clue suggestive of hypercalcemia.
Appendix
Available only for authorised users
Literature
4.
go back to reference Harrison GN, Lipham M, Elguindi AS, Loebl DH (1979) Acute sarcoidosis occurring during the course of systemic lupus erythematosus. South Med J 72(11):1387–1388CrossRefPubMed Harrison GN, Lipham M, Elguindi AS, Loebl DH (1979) Acute sarcoidosis occurring during the course of systemic lupus erythematosus. South Med J 72(11):1387–1388CrossRefPubMed
5.
go back to reference Braude S, Graham A, Mitchell D (1991) Lymphoedema/hypercalcaemia syndrome mediated by parathyroid-hormone-related protein. Lancet 337(8734):140–141CrossRefPubMed Braude S, Graham A, Mitchell D (1991) Lymphoedema/hypercalcaemia syndrome mediated by parathyroid-hormone-related protein. Lancet 337(8734):140–141CrossRefPubMed
6.
go back to reference Katchan B, Karaplis AC, Begin LR, Trifiro M (1996) Hypercalcaemia with lymphoedema. Lancet 347(8995):161CrossRefPubMed Katchan B, Karaplis AC, Begin LR, Trifiro M (1996) Hypercalcaemia with lymphoedema. Lancet 347(8995):161CrossRefPubMed
7.
go back to reference Deftos LJ, Burton DW, Baird SM, Terkeltaub RA (1996) Hypercalcemia and systemic lupus erythematosus. Arthritis Rheum 39(12):2066–2069CrossRefPubMed Deftos LJ, Burton DW, Baird SM, Terkeltaub RA (1996) Hypercalcemia and systemic lupus erythematosus. Arthritis Rheum 39(12):2066–2069CrossRefPubMed
8.
go back to reference Gazzaruso C, Montecucco CM, Geroldi D, Garzaniti A, Finardi G (2000) Severe hypercalcemia and systemic lupus erythematosus. Joint Bone Spine 67(5):485–488PubMed Gazzaruso C, Montecucco CM, Geroldi D, Garzaniti A, Finardi G (2000) Severe hypercalcemia and systemic lupus erythematosus. Joint Bone Spine 67(5):485–488PubMed
9.
go back to reference Berar-Yanay N, Weiner P, Magadle R (2001) Hypercalcaemia in systemic lupus erythematosus. Clin Rheumatol 20(2):147–149CrossRefPubMed Berar-Yanay N, Weiner P, Magadle R (2001) Hypercalcaemia in systemic lupus erythematosus. Clin Rheumatol 20(2):147–149CrossRefPubMed
10.
go back to reference Erdozain JG, Egurbide MV, Ruiz-Irastorza G, Ojanguren J, Aguirre C (2004) Systemic lupus erythematosus presenting as acute symptomatic hypercalcemia. Lupus 13(2):132–134CrossRefPubMed Erdozain JG, Egurbide MV, Ruiz-Irastorza G, Ojanguren J, Aguirre C (2004) Systemic lupus erythematosus presenting as acute symptomatic hypercalcemia. Lupus 13(2):132–134CrossRefPubMed
11.
go back to reference Khoury J, Jerushalmi J, Mograbi A, Saab A, Loberant N (2005) Lung uptake in a young patient with hypercalcemia who was found to have systemic lupus erythematosus. Clin Nucl Med 30(5):324–325CrossRefPubMed Khoury J, Jerushalmi J, Mograbi A, Saab A, Loberant N (2005) Lung uptake in a young patient with hypercalcemia who was found to have systemic lupus erythematosus. Clin Nucl Med 30(5):324–325CrossRefPubMed
17.
go back to reference Zhang B, Yu X, Mao H, Xing C, Liu J (2013) Late onset systemic lupus erythematosus with severe hypercalcaemia. West Indian Med J 62(1):92–94PubMed Zhang B, Yu X, Mao H, Xing C, Liu J (2013) Late onset systemic lupus erythematosus with severe hypercalcaemia. West Indian Med J 62(1):92–94PubMed
19.
go back to reference Rankin W, Grill V, Martin TJ (1997) Parathyroid hormone-related protein and hypercalcemia. Cancer 80(8 Suppl):1564–1571CrossRefPubMed Rankin W, Grill V, Martin TJ (1997) Parathyroid hormone-related protein and hypercalcemia. Cancer 80(8 Suppl):1564–1571CrossRefPubMed
20.
go back to reference Strain JP, Hill TC, Parker JA, Donohoe KJ, Kolodny GM (2000) Diffuse, intense lung uptake on a bone scan: a case report. Clin Nucl Med 25(8):608–610CrossRefPubMed Strain JP, Hill TC, Parker JA, Donohoe KJ, Kolodny GM (2000) Diffuse, intense lung uptake on a bone scan: a case report. Clin Nucl Med 25(8):608–610CrossRefPubMed
23.
24.
go back to reference Nazir L, Saeed M (2015) The calcium invasion: calciphylaxis in lupus. JPMA 65(4):427–428 Nazir L, Saeed M (2015) The calcium invasion: calciphylaxis in lupus. JPMA 65(4):427–428
Metadata
Title
Systemic lupus erythematosus-related hypercalcemia with ectopic calcinosis
Authors
Lidan Zhao
Linfang Huang
Xuan Zhang
Publication date
01-07-2016
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 7/2016
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-016-3486-3

Other articles of this Issue 7/2016

Rheumatology International 7/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.